Histogen Inc. (NASDAQ:HSTO – Get Free Report)’s share price traded up 533.3% during mid-day trading on Wednesday . The company traded as high as $0.19 and last traded at $0.19. 1,685,815 shares were traded during trading, an increase of 16,158% from the average session volume of 10,369 shares. The stock had previously closed at $0.03.
Histogen Stock Performance
The stock has a market cap of $132,583.50, a PE ratio of -0.01 and a beta of 1.19. The company’s 50-day moving average price is $0.03 and its 200 day moving average price is $0.11.
About Histogen
Histogen Inc, a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function. The company’s product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases.
Featured Stories
- Five stocks we like better than Histogen
- Growth Stocks: What They Are, Examples and How to Invest
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- How to Profit From Value Investing
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Histogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Histogen and related companies with MarketBeat.com's FREE daily email newsletter.
